Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile

被引:7
|
作者
Brebi, Priscilla [1 ,2 ]
Gloria Ili, Carmen [1 ,2 ]
Andana, Alejandra [1 ,2 ]
Menzel, Doris [1 ,2 ]
Lopez, Jaime [1 ,2 ]
Guzman, Pablo [1 ]
Melo, Angelica [2 ]
Buchegger, Kurt [1 ,2 ]
Roa, Juan C. [3 ,4 ]
机构
[1] Univ La Frontera, Fac Med, Dept Anat Patol, Lab Patol Mol, Casilla 54-D, Temuco, Chile
[2] Univ La Frontera, Ctr Excelencia Med Traslac Sci & Technol Bioresou, Casilla 54-D, Temuco, Chile
[3] Pontificia Univ Catolica Chile, Sch Med, Dept Pathol, Marcoleta 377,7th Floor, Santiago, Chile
[4] Millennium Inst Immunol & Immunotherapy P09 016 F, Adv Ctr Chron Dis ACCDiS, Santiago, Chile
关键词
Human papillomavirus; Cervical intraepithelial neoplasia; Cervical cancer; Polymerase chain reaction; Reverse line blotting assay; HYBRID-CAPTURE-II; HPV TYPES; NATURAL-HISTORY; VIRUS; PREVALENCE; LESIONS; IDENTIFICATION; EPIDEMIOLOGY; WORLDWIDE; INFECTION;
D O I
10.1186/s12885-017-3496-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) is the etiological factor for cervical cancer and its precursor lesions. The characterization of HPV genotypes in preneoplastic lesions and cervical cancer could establishes the effectiveness of vaccination plan in Chilean population. The aim of this study was to determine HPV frequency in a group of women including in a cervical screening program in the public health care system in Chile. Methods: We analyzed 985 cervical smears samples from women with different histological diagnosis, attending to public health care in Temuco-Chile between 2004 and 2012, to detect HPV genotypes, through PCR followed by reverse line blotting assay. Results: HPV was found present in 80.8% (n = 796) of samples. Only a 5.6% of 985 samples were infected with a low-risk HPV, considering multiple infections. 10.5% (n = 8/76) of normal cervical epithelia, 83.5% (n = 208/249) and 87.6% (n = 557/636) of low and high grade squamous intraepithelial lesions, respectively, and 95.8% (n = 23/24) of squamous cervical carcinomas tested positive for HPV. HPV 16 was the most frequent genotype found (Overall 44.9%, n = 442/985; SCC: 62.5%, n = 15/24). A high variability of HPV types was also found in preneoplastic lesions, whereas there was a selection of genotypes in neoplasia. Also, there was a higher risk of infection with HPV 16 in women <= 26 years and 34-41 years old (p < 0.05), meanwhile infections with HPV 16 or HPV 18 have related with cancer development (p < 0.01). Conclusions: These data provide further information about the frequency of HPV genotypes in women with cervical lesions in Chile, and the introduction of new targeted vaccines against a wider spectrum of HPV is suggested.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
    Priscilla Brebi
    Carmen Gloria Ili
    Alejandra Andana
    Doris Menzel
    Jaime Lopez
    Pablo Guzman
    Angelica Melo
    Kurt Buchegger
    Juan C. Roa
    BMC Cancer, 17
  • [2] Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium
    Arbyn, Marc
    Benoy, Ina
    Simoens, Cindy
    Bogers, Johannes
    Beutels, Philippe
    Depuydt, Christophe
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) : 321 - 330
  • [3] Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe
    Mandishora, Racheal S. Dube
    Christiansen, Irene K.
    Chin'ombe, Nyasha
    Duri, Kerina
    Ngara, Bernard
    Rounge, Trine B.
    Meisal, Roger
    Ambur, Ole H.
    Palefsky, Joel M.
    Stray-Pedersen, Babill
    Chirenje, Zvavahera M.
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (09) : 1671 - 1677
  • [4] Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014–2015
    Monserrat Balanda
    Andrea Quiero
    Nicolás Vergara
    Gloria Espinoza
    Héctor San Martín
    Giovanna Rojas
    Eugenio Ramírez
    Medical Microbiology and Immunology, 2016, 205 : 585 - 594
  • [5] Human papillomavirus infections and cervical cancer screening in Tunisian women
    Bouguerra, H.
    Hechaichi, A.
    Letaief, H.
    Ardhaoui, M.
    Ennaiefer, E.
    Bougatef, S.
    Chahed, K.
    Mechala, M.
    Boubaker, S.
    Ben Alaya, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29
  • [6] Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
    M K Leinonen
    A Anttila
    N Malila
    J Dillner
    O Forslund
    P Nieminen
    British Journal of Cancer, 2013, 109 : 2941 - 2950
  • [7] Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic
    Brown, C. R.
    Leon, M. L.
    Munoz, K.
    Fagioni, A.
    Amador, L. G.
    Frain, B.
    Tu, W.
    Qadadri, B.
    Brown, D. R.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (07) : 629 - 636
  • [8] Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea
    Oh, Jin-Kyoung
    Franceschi, Silvia
    Kim, Bu-Kyung
    Kim, Ji-Young
    Ju, Young-Hee
    Hong, Eun-Kyung
    Chang, Young-Chul
    Rha, Seo-Hee
    Kim, Hyun-Ho
    Kim, Jung-Hye
    Kim, Chang-Young
    Shin, Hai-Rim
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (01) : 56 - 61
  • [9] Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
    Leinonen, M. K.
    Anttila, A.
    Malila, N.
    Dillner, J.
    Forslund, O.
    Nieminen, P.
    BRITISH JOURNAL OF CANCER, 2013, 109 (11) : 2941 - 2950
  • [10] Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries
    Robles, Claudia
    Bruni, Laia
    Acera, Amelia
    Riera, Joan Carles
    Prats, Laia
    Poljak, Mario
    Mlakar, Jana
    Valencak, Anja Ostrbenk
    Eriksson, Tiina
    Lehtinen, Matti
    Louvanto, Karolina
    Hortlund, Maria
    Dillner, Joakim
    Faber, Mette T.
    Munk, Christian
    Kjaer, Susanne K.
    Petry, Karl Ulrich
    Denecke, Agnieszka
    Xu, Lan
    Arbyn, Marc
    Cadman, Louise
    Cuzick, Jack
    Dalstein, Veronique
    Clavel, Christine
    de Sanjose, Silvia
    Bosch, F. Xavier
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 60 (04) : 478 - 487